The most common EGFR variant is a deletion of exons 2–7, EGFRvIII, which often co-occurs with focal EGFR amplification, which together are associated with a more aggressive, immuno-evasive tumour phenotype and worse prognosis [6]. Here, EGFR is linked to neoplasm.